These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 6434764)

  • 1. [Distribution, metabolism and excretion of 14C-MT-141 in rats. I. Distribution, metabolism and excretion after single intravenous administration in male rats].
    Komiya I; Ishizuka T; Nishio M; Murata S; Esumi Y; Washino T; Matsunaga K; Mitsugi K; Yokoshima T
    Jpn J Antibiot; 1984 May; 37(5):927-37. PubMed ID: 6434764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Distribution, metabolism and excretion of 14C-MT-141 in rats. II. Distribution and excretion after multiple intravenous administration in male rats and after single intravenous administration in female rats].
    Komiya I; Ishizuka T; Nishio M; Murata S; Esumi Y; Washino T; Matsunaga K; Takaichi M; Yokoshima T
    Jpn J Antibiot; 1984 May; 37(5):938-49. PubMed ID: 6434765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on absorption, distribution and excretion of 14C labelled sodium 7 beta-[(2R, 3S)-2-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-3-hydroxybutanamido]-7-methoxy-3-[(1-methyl-1H-tetrazol-5-YL)thiomethyl]-3-cephem-4-carboxylate (14C-T-1982) in mice and rats].
    Saikawa I; Takai A; Nakashima Y; Ikegami T; Hayakawa H; Noguchi M; Yamauchi H; Shimizu H
    Jpn J Antibiot; 1982 Sep; 35(9):2163-73. PubMed ID: 7143717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
    Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H
    Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.
    Sugimoto T; Hayashi T; Okita A; Morino A
    Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of 4-acetylaminophenylacetic acid. 1st communication: absorption, distribution, metabolism and excretion in mice, rats, dogs and monkeys after single administration of 14C-labeled compound.
    Sugihara K; Morino A; Nomura A; Iida S; Sugiyama M
    Arzneimittelforschung; 1990 Jul; 40(7):800-5. PubMed ID: 2222556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on absorption, distribution and excretion of 14C labeled (+-)-7-(3-amino-1-pyrrolidinyl)-6-fluoro-1-(2,4-difluorophenyl)-1,4- dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid p-toluene-sulfonate hydrate (14C-T-3262) in rats and mice].
    Maeda T; Sakai H; Hayakawa H; Hayashi K; Yoneda K
    Jpn J Antibiot; 1989 Apr; 42(4):854-67. PubMed ID: 2769938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on absorption, distribution and excretion of 14C labeled pivaloyloxymethyl (+)-(6R,7R)- 7-[(Z)-2-(2-amino-4-thiazolyl)-2-methoxyiminoacetamido]- 3-[(5-methyl-2H-tetrazol-2-yl)methyl]-8-oxo-5-thia- 1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate (14C-T-2588) in rats and mice].
    Saikawa I; Maeda T; Nakashima Y; Sakai H; Hayakawa H; Onoda M; Matsutani H
    Jpn J Antibiot; 1986 Apr; 39(4):979-90. PubMed ID: 3761551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disposition and metabolism of [14C]-haloperidol in rats.
    Miyazaki H; Matsunaga Y; Nambu K; Oh-e Y; Yoshida K; Hashimoto M
    Arzneimittelforschung; 1986 Mar; 36(3):443-52. PubMed ID: 3707663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Metabolic fate of 14C-isepamicin sulfate (14C-HAPA-B) in rats. I. Absorption, distribution, metabolism and excretion after a single intramuscular and intravenous administration].
    Iwasaki M; Serizawa K; Suzuki T; Morishita M; Takahashi T; Muranishi S
    Jpn J Antibiot; 1987 Jan; 40(1):239-52. PubMed ID: 3586333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 2nd communication: distribution and transfer into the fetus and milk after a single intravenous administration and pharmacokinetics and enzyme induction after repeated intravenous administration to rats.
    Sugimoto T; Hayashi T; Okita A; Morino A
    Arzneimittelforschung; 1996 Feb; 46(2):114-27. PubMed ID: 8720299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorption, distribution and excretion of radioactivity after a single intravenous or oral administration of [14C] glucosamine to the rat.
    Setnikar I; Giachetti C; Zanolo G
    Pharmatherapeutica; 1984; 3(8):538-50. PubMed ID: 6422479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Absorption, distribution, excretion and metabolism of [14C] T-3761 in rats and mice].
    Hayakawa H; Hayashi K; Sakai H; Ishikura H; Takagi H; Nakajima Y; Sogame Y
    Jpn J Antibiot; 1995 May; 48(5):671-85. PubMed ID: 7637202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
    Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
    Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.
    Okuyama Y; Momota K; Morino A
    Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetics and disposition of a new anticancer antibiotic (2''R)-4'-O-tetrahydropyranyladriamycin in rats. Distribution and excretion after a single administration].
    Tone H; Iguchi H; Fujigaki M; Nishio M; Esumi Y; Takaichi M; Tsutsumi S; Yokoshima T
    Jpn J Antibiot; 1986 Feb; 39(2):612-28. PubMed ID: 3712761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study on the metabolic fate of catena-(S)-[mu-[N alpha-(3- aminopropionyl)histidinato(2-)-N1,N2,O:N tau]-zinc]. 1st communication: absorption, distribution, metabolism and excretion after single administration to rats.
    Sano H; Furuta S; Toyama S; Miwa M; Ikeda Y; Suzuki M; Sato H; Matsuda K
    Arzneimittelforschung; 1991 Sep; 41(9):965-75. PubMed ID: 1796927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105.
    Mukai H; Sugimoto T; Ago M; Morino A
    Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.